Metoprolol Succinate Extended Release Tablets

Country: Նոր Զելանդիա

language: անգլերեն

source: Medsafe (Medicines Safety Authority)

active_ingredient:

Metoprolol succinate 23.75mg equivalent to metoprolol tartrate 25mg

MAH:

AFT Pharmaceuticals Ltd

INN:

Metoprolol succinate 23.75 mg (equivalent to metoprolol tartrate 25mg)

dosage:

23.75 mg

pharmaceutical_form:

Modified release tablet

composition:

Active: Metoprolol succinate 23.75mg equivalent to metoprolol tartrate 25mg Excipient: Cellulose acetate Crospovidone Glyceryl monostearate Hypromellose Methacrylic acid copolymer Microcrystalline cellulose Opadry clear YS-1-7006 Opadry white YS-1-7003 Poloxamer 188 Polysorbate 80 Sugar spheres

prescription_type:

Prescription

manufactured_by:

Watson Pharma Private Limited

therapeutic_indication:

Metoprolol Succinate Extended-Release Tablets are indicated for the treatment of: Hypertension - to lower blood pressure. Lowering blood pressure reduces the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions.

leaflet_short:

Package - Contents - Shelf Life: Bottle, plastic, HDPE bottle with PP cap - 100 tablets - 36 months from date of manufacture stored at or below 25°C

authorization_date:

2016-06-24